We are honored to be selected by Fierce Life Sciences as a finalist for their annual Innovation Awards. At Cytonus, we have had to educate many people about a new path forward in pharma and biotech and that isn’t always an easy thing for people to accept. This recognition further emphasizes that our approach, backed by solid data is beginning to resonate. As a co-founder I have seen our Cargocyte meet and exceed all challenges we have thrown at it biologically. The fact that we are the only pre-clinical company as a finalist speaks volumes about the Cargocyte and our company.
Best regards,
Remo Moomiaie-Qajar, M.D.
CEO
Cytonus
To learn more:
Fierce Life Sciences Innovation Awards
